Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bahra

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 30, 2025
The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patientsFrançois Schneider, Haotian Chen, Uwe Pelzer, et al.
Oncoimmunology|September 19, 2017
Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinomaGeorgi Atanasov, Corinna Dietel, Linda Feldbrügge, et al.
Hepatology (Baltimore, Md.)|March 18, 2009
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomasMarc-Oliver Riener, Frank Stenner, Heike Liewen, et al.
Cancer Cell International|September 13, 2025
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoidsKatharina Wansch, Uwe Pelzer, François Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialMarianne Sinn, Marcus Bahra, Torsten Liersch, et al.
Plos Computational Biology|May 23, 2012
Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genesChristof Winter, Glen Kristiansen, Stephan Kersting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2017
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment ResponseAlexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 8, 2015
CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantationNathanael Raschzok, Anja Reutzel-Selke, Rosa Bianca Schmuck, et al.
The British Journal of Surgery|March 17, 2023
Initial learning curves of laparoscopic and robotic distal pancreatectomy compared with open distal pancreatectomy: multicentre analysisFelix Nickel, Marius Distler, Eldridge F Limen, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2020
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trialVolker Kunzmann, Jens T Siveke, Hana Algül, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|December 30, 2025
The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patientsFrançois Schneider, Haotian Chen, Uwe Pelzer, et al.
Oncoimmunology|September 19, 2017
Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinomaGeorgi Atanasov, Corinna Dietel, Linda Feldbrügge, et al.
Hepatology (Baltimore, Md.)|March 18, 2009
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomasMarc-Oliver Riener, Frank Stenner, Heike Liewen, et al.
Cancer Cell International|September 13, 2025
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoidsKatharina Wansch, Uwe Pelzer, François Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialMarianne Sinn, Marcus Bahra, Torsten Liersch, et al.
Plos Computational Biology|May 23, 2012
Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genesChristof Winter, Glen Kristiansen, Stephan Kersting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2017
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment ResponseAlexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 8, 2015
CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantationNathanael Raschzok, Anja Reutzel-Selke, Rosa Bianca Schmuck, et al.
The British Journal of Surgery|March 17, 2023
Initial learning curves of laparoscopic and robotic distal pancreatectomy compared with open distal pancreatectomy: multicentre analysisFelix Nickel, Marius Distler, Eldridge F Limen, et al.
The Lancet. Gastroenterology & Hepatology|December 18, 2020
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trialVolker Kunzmann, Jens T Siveke, Hana Algül, et al.
Pageof 18